Cargando…
Development of Clostridium saccharoperbutylacetonicum as a Whole Cell Biocatalyst for Production of Chirally Pure (R)-1,3-Butanediol
Chirally pure (R)-1,3-butanediol ((R)-1,3-BDO) is a valuable intermediate for the production of fragrances, pheromones, insecticides and antibiotics. Biotechnological production results in superior enantiomeric excess over chemical production and is therefore the preferred production route. In this...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8155681/ https://www.ncbi.nlm.nih.gov/pubmed/34055760 http://dx.doi.org/10.3389/fbioe.2021.659895 |
_version_ | 1783699261976739840 |
---|---|
author | Grosse-Honebrink, Alexander Little, Gareth T. Bean, Zak Heldt, Dana Cornock, Ruth H. M. Winzer, Klaus Minton, Nigel P. Green, Edward Zhang, Ying |
author_facet | Grosse-Honebrink, Alexander Little, Gareth T. Bean, Zak Heldt, Dana Cornock, Ruth H. M. Winzer, Klaus Minton, Nigel P. Green, Edward Zhang, Ying |
author_sort | Grosse-Honebrink, Alexander |
collection | PubMed |
description | Chirally pure (R)-1,3-butanediol ((R)-1,3-BDO) is a valuable intermediate for the production of fragrances, pheromones, insecticides and antibiotics. Biotechnological production results in superior enantiomeric excess over chemical production and is therefore the preferred production route. In this study (R)-1,3-BDO was produced in the industrially important whole cell biocatalyst Clostridium saccharoperbutylacetonicum through expression of the enantio-specific phaB gene from Cupriavidus necator. The heterologous pathway was optimised in three ways: at the transcriptional level choosing strongly expressed promoters and comparing plasmid borne with chromosomal gene expression, at the translational level by optimising the codon usage of the gene to fit the inherent codon adaptation index of C. saccharoperbutylacetonicum, and at the enzyme level by introducing point mutations which led to increased enzymatic activity. The resulting whole cell catalyst produced up to 20 mM (1.8 g/l) (R)-1,3-BDO in non-optimised batch fermentation which is a promising starting position for economical production of this chiral chemical. |
format | Online Article Text |
id | pubmed-8155681 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-81556812021-05-28 Development of Clostridium saccharoperbutylacetonicum as a Whole Cell Biocatalyst for Production of Chirally Pure (R)-1,3-Butanediol Grosse-Honebrink, Alexander Little, Gareth T. Bean, Zak Heldt, Dana Cornock, Ruth H. M. Winzer, Klaus Minton, Nigel P. Green, Edward Zhang, Ying Front Bioeng Biotechnol Bioengineering and Biotechnology Chirally pure (R)-1,3-butanediol ((R)-1,3-BDO) is a valuable intermediate for the production of fragrances, pheromones, insecticides and antibiotics. Biotechnological production results in superior enantiomeric excess over chemical production and is therefore the preferred production route. In this study (R)-1,3-BDO was produced in the industrially important whole cell biocatalyst Clostridium saccharoperbutylacetonicum through expression of the enantio-specific phaB gene from Cupriavidus necator. The heterologous pathway was optimised in three ways: at the transcriptional level choosing strongly expressed promoters and comparing plasmid borne with chromosomal gene expression, at the translational level by optimising the codon usage of the gene to fit the inherent codon adaptation index of C. saccharoperbutylacetonicum, and at the enzyme level by introducing point mutations which led to increased enzymatic activity. The resulting whole cell catalyst produced up to 20 mM (1.8 g/l) (R)-1,3-BDO in non-optimised batch fermentation which is a promising starting position for economical production of this chiral chemical. Frontiers Media S.A. 2021-05-13 /pmc/articles/PMC8155681/ /pubmed/34055760 http://dx.doi.org/10.3389/fbioe.2021.659895 Text en Copyright © 2021 Grosse-Honebrink, Little, Bean, Heldt, Cornock, Winzer, Minton, Green and Zhang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Bioengineering and Biotechnology Grosse-Honebrink, Alexander Little, Gareth T. Bean, Zak Heldt, Dana Cornock, Ruth H. M. Winzer, Klaus Minton, Nigel P. Green, Edward Zhang, Ying Development of Clostridium saccharoperbutylacetonicum as a Whole Cell Biocatalyst for Production of Chirally Pure (R)-1,3-Butanediol |
title | Development of Clostridium saccharoperbutylacetonicum as a Whole Cell Biocatalyst for Production of Chirally Pure (R)-1,3-Butanediol |
title_full | Development of Clostridium saccharoperbutylacetonicum as a Whole Cell Biocatalyst for Production of Chirally Pure (R)-1,3-Butanediol |
title_fullStr | Development of Clostridium saccharoperbutylacetonicum as a Whole Cell Biocatalyst for Production of Chirally Pure (R)-1,3-Butanediol |
title_full_unstemmed | Development of Clostridium saccharoperbutylacetonicum as a Whole Cell Biocatalyst for Production of Chirally Pure (R)-1,3-Butanediol |
title_short | Development of Clostridium saccharoperbutylacetonicum as a Whole Cell Biocatalyst for Production of Chirally Pure (R)-1,3-Butanediol |
title_sort | development of clostridium saccharoperbutylacetonicum as a whole cell biocatalyst for production of chirally pure (r)-1,3-butanediol |
topic | Bioengineering and Biotechnology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8155681/ https://www.ncbi.nlm.nih.gov/pubmed/34055760 http://dx.doi.org/10.3389/fbioe.2021.659895 |
work_keys_str_mv | AT grossehonebrinkalexander developmentofclostridiumsaccharoperbutylacetonicumasawholecellbiocatalystforproductionofchirallypurer13butanediol AT littlegaretht developmentofclostridiumsaccharoperbutylacetonicumasawholecellbiocatalystforproductionofchirallypurer13butanediol AT beanzak developmentofclostridiumsaccharoperbutylacetonicumasawholecellbiocatalystforproductionofchirallypurer13butanediol AT heldtdana developmentofclostridiumsaccharoperbutylacetonicumasawholecellbiocatalystforproductionofchirallypurer13butanediol AT cornockruthhm developmentofclostridiumsaccharoperbutylacetonicumasawholecellbiocatalystforproductionofchirallypurer13butanediol AT winzerklaus developmentofclostridiumsaccharoperbutylacetonicumasawholecellbiocatalystforproductionofchirallypurer13butanediol AT mintonnigelp developmentofclostridiumsaccharoperbutylacetonicumasawholecellbiocatalystforproductionofchirallypurer13butanediol AT greenedward developmentofclostridiumsaccharoperbutylacetonicumasawholecellbiocatalystforproductionofchirallypurer13butanediol AT zhangying developmentofclostridiumsaccharoperbutylacetonicumasawholecellbiocatalystforproductionofchirallypurer13butanediol |